Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II TrialJ. Nucl. Med. 2022 Apr 01;63(4)560-566, S Pathmanandavel, M Crumbaker, AO Yam, A Nguyen, C Rofe, E Hovey, C Gedye, EM Kwan, C Hauser, AA Azad, P Eu, AJ Martin, AM Joshua, L Emmett
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.